{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T10:18:06Z","timestamp":1779272286753,"version":"3.51.4"},"reference-count":35,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Background: Pemphigus vulgaris (PV) is an IgG-mediated autoimmune disease characterised by epithelial cell\u2013cell detachment (acantholysis) resulting in mucocutaneous blistering. The exact pathogenesis of blister formation is unknown and this has hampered the development of non-steroidal, mechanism-based treatments for this autoimmune disease. This systematic review aims to investigate the role of caspases in the pathogenesis of PV to inform the choice of more targeted therapeutic agents. Methods: A systematic search of MEDLINE\/PubMed and Scopus databases was conducted to identify eligible studies. Multiple phases of inclusion and exclusion of the primary articles were conducted in pairs, and studies were recorded and analysed according to the latest version of the preferred reporting items for systematic reviews and meta-analyses (PRISMA). Risk of bias assessment was conducted for extracted in vivo animal intervention studies using SYRCLE\u2019s risk of bias tool. Results: Eight articles from a total of 2338 in vitro, in vivo, and human studies met the inclusion criteria, with a high degree of inter-rater reliability. By and large, the results show that caspase activation was pathogenic in experimental PV because pan-caspase inhibitors could block or reduce PV acantholysis and blistering in vitro and in vivo, respectively. The pathogenic pathways identified involved caspase-1 and caspase-3. One study failed to show any improvement in the PV model with a caspase inhibitor. The majority of animal studies had high or unclear risk of bias. Conclusion: There are consistent data pointing towards a pathogenic role of caspase activation in PV acantholysis. However, high-quality evidence to confirm that caspase inhibition can prevent PV-induced blistering in vivo is limited. Therefore, further research is required to test the preclinical efficacy of caspase inhibitors in PV.<\/jats:p>","DOI":"10.3390\/biology11020314","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T20:26:41Z","timestamp":1645043201000},"page":"314","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Caspase Inhibition as a Possible Therapeutic Strategy for Pemphigus Vulgaris: A Systematic Review of Current Evidence"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1055-9436","authenticated-orcid":false,"given":"Sanna","family":"Huda","sequence":"first","affiliation":[{"name":"Melbourne Dental School, The University of Melbourne, Carlton, VIC 3053, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bethany","family":"Chau","sequence":"additional","affiliation":[{"name":"Melbourne Dental School, The University of Melbourne, Carlton, VIC 3053, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanqi","family":"Chen","sequence":"additional","affiliation":[{"name":"Melbourne Dental School, The University of Melbourne, Carlton, VIC 3053, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Somal","sequence":"additional","affiliation":[{"name":"Melbourne Dental School, The University of Melbourne, Carlton, VIC 3053, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neiloy","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Melbourne Dental School, The University of Melbourne, Carlton, VIC 3053, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1429-1323","authenticated-orcid":false,"given":"Nicola","family":"Cirillo","sequence":"additional","affiliation":[{"name":"Melbourne Dental School, The University of Melbourne, Carlton, VIC 3053, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2165\/11316810-000000000-00000","article-title":"Novel therapies for pemphigus vulgaris","volume":"26","author":"Perez","year":"2009","journal-title":"Drugs Aging"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus","volume":"394","author":"Schmidt","year":"2019","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): A prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4103\/jomfp.JOMFP_143_17","article-title":"Current concepts of pemphigus with a deep insight into its molecular aspects","volume":"21","author":"Madala","year":"2017","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s004030050347","article-title":"Relationship between keratinocyte adhesion and death: Anoikis in acantholytic diseases","volume":"290","author":"Gniadecki","year":"1998","journal-title":"Arch. Dermatol. Res."},{"key":"ref_6","first-page":"563091","article-title":"The caspase pathway as a possible therapeutic target in experimental pemphigus","volume":"2011","year":"2011","journal-title":"Autoimmune Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1196\/annals.1313.040","article-title":"The interaction of pemphigus autoimmunoglobulins with epidermal cells: Activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients","volume":"1050","author":"Pergamentz","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1590\/abd1806-4841.20164598","article-title":"Detection of apoptosis in pemphigus vulgaris by TUNEL technique","volume":"91","year":"2016","journal-title":"An. Bras. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/jop.12022","article-title":"Study of apoptosis in oral pemphigus vulgaris using immunohistochemical marker Bax and TUNEL technique","volume":"42","author":"Deyhimi","year":"2013","journal-title":"J. Oral Pathol. Med."},{"key":"ref_10","first-page":"132","article-title":"Study of extrinsic apoptotic pathway in oral pemphigus vulgaris using TNFR 1 and FasL immunohistochemical markers and TUNEL technique","volume":"19","author":"Deyhimi","year":"2018","journal-title":"J. Dent."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1600-0625.2009.00893.x","article-title":"An imbalance in Akt\/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris","volume":"18","author":"Pretel","year":"2009","journal-title":"Exp. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/B:APPT.0000018795.05766.1f","article-title":"Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins","volume":"9","author":"Wang","year":"2004","journal-title":"Apoptosis"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"41175","DOI":"10.1074\/jbc.M105769200","article-title":"The fate of desmosomal proteins in apoptotic cells","volume":"276","author":"Weiske","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kaur, B., Kerbrat, J., Kho, J., Kaler, M., Kanatsios, S., and Cirillo, N. (2021). Mechanism-based therapeutic targets of pemphigus vulgaris: A scoping review of pathogenic intracellular pathways. Exp. Dermatol.","DOI":"10.1111\/exd.14453"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Hooijmans, C.R., Rovers, M.M., De Vries, R.B., Leenaars, M., Ritskes-Hoitinga, M., and Langendam, M.W. (2014). SYRCLE\u2019s risk of bias tool for animal studies. BMC Med. Res. Methodol., 14.","DOI":"10.1186\/1471-2288-14-43"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/exd.13458","article-title":"Feasibility study for clinical application of caspase-3 inhibitors in Pemphigus vulgaris","volume":"26","author":"Hariton","year":"2017","journal-title":"Exp. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0002-9440(10)61239-4","article-title":"Novel Mechanisms of Target Cell Death and Survival and of Therapeutic Action of IVIg in Pemphigus","volume":"167","author":"Arredondo","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1600-0625.2012.01441.x","article-title":"Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris","volume":"21","author":"Gil","year":"2012","journal-title":"Exp. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Luyet, C., Schulze, K., Sayar, B.S., Howald, D., M\u00fcller, E.J., and Galichet, A. (2015). Preclinical Studies Identify Non-Apoptotic Low-Level Caspase-3 as Therapeutic Target in Pemphigus Vulgaris. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119809"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"C162","DOI":"10.1152\/ajpcell.00161.2008","article-title":"Apoptosis is not required for acantholysis in pemphigus vulgaris","volume":"296","author":"Schmidt","year":"2009","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jcb.21431","article-title":"The most widespread desmosomal cadherin, desmoglein 2, is a novel target of caspase 3-mediated apoptotic machinery","volume":"103","author":"Cirillo","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1365-2133.2006.07654.x","article-title":"Caspase-dependent cleavage of desmoglein 1 depends on the apoptotic stimulus","volume":"156","author":"Lanza","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1523-1747.2003.12014.x","article-title":"Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8","volume":"120","author":"Puviani","year":"2003","journal-title":"J. Investig. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1074\/jbc.M109.081570","article-title":"Antimitochondrial Autoantibodies in Pemphigus Vulgaris: A MISSING LINK IN DISEASE PATHOPHYSIOLOGY 2","volume":"285","author":"Marchenko","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/jid.2003.10","article-title":"Genomic sequence analysis of the mouse desmoglein cluster reveals evidence for six distinct genes: Characterization of mouse DSG4, DSG5, and DSG6","volume":"120","author":"Whittock","year":"2003","journal-title":"J. Investig. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1468-3083.2009.03162.x","article-title":"The final destiny of acantholytic cells in pemphigus is Fas mediated","volume":"23","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"12855","DOI":"10.1073\/pnas.0602973103","article-title":"p38MAPK inhibition prevents disease in pemphigus vulgaris mice","volume":"103","author":"Berkowitz","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/exd.12290","article-title":"EGFR inhibitors erlotinib and lapatinib ameliorate epidermal blistering in pemphigus vulgaris in a non-linear, V-shaped relationship","volume":"23","author":"Sayar","year":"2014","journal-title":"Exp. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1038\/sj.emboj.7601224","article-title":"Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin","volume":"25","author":"Williamson","year":"2006","journal-title":"EMBO J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cmdc.200900531","article-title":"A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety","volume":"5","author":"Williamson","year":"2010","journal-title":"Chem. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fimmu.2018.00370","article-title":"Soluble Fas Ligand is Essential for Blister Formation in Pemphigus","volume":"9","author":"Lotti","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jcp.20997","article-title":"Defining the involvement of proteinases in pemphigus vulgaris: Evidence of matrix metalloproteinase-9 overexpression in experimental models of disease","volume":"212","author":"Cirillo","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Cirillo, N., and Prime, S.S. (2021). A Scoping Review of the Role of Metalloproteinases in the Pathogenesis of Autoimmune Pemphigus and Pemphigoid. Biomolecules, 11.","DOI":"10.3390\/biom11101506"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41419-021-04240-3","article-title":"A long way to go: Caspase inhibitors in clinical use","volume":"12","author":"Dhani","year":"2021","journal-title":"Cell Death Dis."}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/11\/2\/314\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:20:33Z","timestamp":1760134833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/11\/2\/314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["biology11020314"],"URL":"https:\/\/doi.org\/10.3390\/biology11020314","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,16]]}}}